Cromos Pharma and Avance Clinical Offer Scalable Clinical Trial Solution for Biotech

1. Пилот, разборы, ответы и лайвы

CONTACT

INQUIRY@CROMOSPHARMA.COM

To arrange an introductory meeting and find out how our experience can benefit your next clinical project.

OUR PUBLICATIONS

PMBoK, ISO 9001, and ICH GCP: Three Pillars of Quality in Clinical Research | Cromos Pharma
PMBoK, ISO 9001, and ICH GCP: Three Pillars of Quality in Clinical Research
Clinical Research Focus 30th edition | Cromos Pharma
Clinical Research Focus. 30th Edition
Transform Clinical Trial Practices with ICH GCP E6 R3 | Cromos Pharma
Major Enhancements Set to Transform Clinical Trial Practices with ICH GCP E6 R3
Digital Twins in Clinical Research: Revolutionizing Study Design | Cromos pharma
Digital Twins in Clinical Research: Revolutionizing Study Design
FDA's New Guidelines Impacting Clinical Trials and Gene Therapy | Cromos Pharma
FDA’s Comprehensive New Guidelines Impacting Clinical Trials and Gene Therapy
Key Takeaways From The 2024 ASCO Annual Meeting
Clinical Research Focus 29th Edition June | Cromos Pharma
Clinical Research Focus. 29th Edition
Clinical Trials Day 2024 | Cromos Pharma
Celebrating Clinical Trials Day: Highlighting the Outside-the-Box Studies that Push the Boundaries
Clinical Research Focus 28th Edition May | Cromos Pharma
Clinical Research Focus. 28th Edition
Clinical Trials in Ukraine 2024 | Cromos Pharma
Ukraine Strives to Remain a Hub for Clinical Trials Despite Conflict
Meet Vlad Bogin at the ASCO Annual Meeting 2024 | Cromos Pharma
Anticipating ASCO: Key Trends in Oncology Clinical Research
Rezdiffra Approval | Cromos Pharma
Rezdiffra Approval Sheds Light on the Challenges of NASH Diagnosis and Fibrosis Identification
Clinical Trials in Georgia 2024 | Cromos Pharma
Сlinical Trials in Georgia 2024
Clinical Research Focus 27bth Edition April | Cromos Pharma
Clinical Research Focus. 27th Edition
The Impact of US-China Tensions on Biopharmaceutical Innovation | Cromos Pharma
Navigating the Challenges: The Impact of US-China Tensions on Biopharmaceutical Innovation
Hungary Country Profile 2024 | Cromos Pharma
Exploring Clinical Trial Opportunities: Hungary’s 2024 Country Profile
World Kidney Day 2024 | Cromos Pharma
World Kidney Day 2024
Clinical Research Focus 26th edition | Cromos Pharma
Clinical Research Focus. 26th Edition
Celebrating Rare Disease Day 2024 | Cromos Pharma
Celebrating Rare Disease Day 2024
Clinical Research Focus 25th edition | Cromos Pharma
Clinical Research Focus. 25th Edition
The FDA’s Latest Guidance on Human Genome Editing | Cromos Pharma
Navigating the Future of Gene Therapy
Regulatory Updates and Simplified Processes in Türkiye | Cromos Pharma
Türkiye’s Emerging Role in Clinical Research: Regulatory Updates and Simplified Processes
J.P. Morgan Healthcare Conference 2024 Key Insights | Cromos Pharma
J.P. Morgan’s Healthcare Conference: A Glimpse into the Optimistic Pulse of 2024
Pragmatic Clinical Trials in 2024 | Cromos Pharma
Pragmatic Clinical Trials in 2024
Clinical Research Focus 24th edition | Cromos Pharma
Clinical Research Focus. 24th Edition
Key Insights from ASH 2023 | Cromos Pharma
Exploring Groundbreaking Advances: Key Insights from ASH 2023
Key Highlights in Clinical Research and Healthcare for 2023 | Cromos Pharma
Key Highlights in Clinical Research and Healthcare for 2023
Clinical Intelligence Report 7th edition December
Revitalizing Biotech: Navigating Efficient Clinical Trials Amid Financial Constraints
FDA approved Gene Therapies for Sickle Cell Disease | Cromos Pharma
FDA Greenlights Groundbreaking Gene Therapies for Sickle Cell Disease
Clinical Research Focus #23 December | Cromos Pharma
Clinical Research Focus. 23rd Edition